TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Sees Significant Growth in Short Interest
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) was the target of a large increase in short interest in May. As of May 31st, there was short interest totalling 27,100 shares, an increase of 22.1% from the May 15th total of 22,200 shares. Currently, 4.4% of the shares of the stock are sold short. Based on […]